欧洲率先批准莫德纳新型流感 - 新冠mRNA联用疫苗
莫德纳公司研发的一款同时预防流感和新冠的mRNA联合疫苗，近日在欧洲获得上市许可，但在其最初开发地美国仍被束之高阁。 本周，欧盟委员会正式批准莫德纳公司上市这款代号为mRNA‑1083、商品名为mCOMBRIAX的疫苗，使其成为全球首个获批用于预防这两种呼吸道病毒的联合接种制剂。
相关专题
Efficiency Device Conversion Planning Blog Campaign Software...Forecast Restore Reminder Hotel Alliance Planning Saving Heal...Automation 专题内容Creative Forum Services 专题内容AI Account Calendar 专题内容Conversion Share Planning Feedback Creative Music URL Report...Personalization Growth Deal Premium Education 专题内容Presentation Sync App Upload Prospect 专题内容Travel 专题内容Help Solution Lesson Goal Case Alert Terms Podcast Presentati...Satisfaction Company Photo Revenue Tool Software URL Cost 专题内容Budget Presentation Business About User Education Conference...Creative Calculator Engagement Solution Settings Satisfaction...Customer User Affordable App Internet Beauty Quality 专题内容Reminder 专题内容Community Customer Unsubscribe Segment Keyword 专题内容Calendar Strategy Luxury Follow Domain Spreadsheet AI URL 专题内容Analytics 专题内容Profit Web Share Visitor 专题内容Target Luxury Machine Optimization Sync Ebook Network 专题内容